Subclinical decrease in cardiac autonomic and diastolic function in patients with metabolic disorders: HSCAA study
Akiko Morimoto1, Manabu Kadoya1, Miki Kakutani-Hatayama1
1Division of Diabetes, Endocrinology and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, 663-8501, Japan.
Insights
Metabolic disorders like diabetes and obesity are linked to reduced cardiac autonomic and diastolic functions, potentially predicting heart failure with preserved ejection fraction (HFpEF). Early detection of autonomic dysfunction may aid in managing pre-heart failure conditions.
Area of Science:
- Cardiology
- Metabolic Syndrome
- Autonomic Nervous System
Background:
- Heart failure with preserved ejection fraction (HFpEF) is a growing concern, particularly in patients with metabolic disorders.
- Subclinical cardiac dysfunction often precedes overt HFpEF, highlighting the need for early detection markers.
Purpose of the Study:
- To investigate the relationship between cardiac autonomic function and diastolic function in individuals with metabolic diseases.
- To identify potential predictors of diastolic dysfunction in a pre-heart failure population.
Main Methods:
- The study analyzed 605 patients with metabolic diseases, assessing cardiac autonomic function (e.g., SDNN, HF) and diastolic function (E/A ratio).
- Statistical analyses were performed to determine associations between metabolic parameters, autonomic function, and diastolic function, controlling for confounders.
Main Results:
- Glucose intolerance, diabetes, and visceral adiposity were significantly associated with impaired cardiac autonomic and diastolic functions.
- Higher autonomic function (SDNN, HF) correlated with better diastolic function (E/A), independent of diabetes, BMI, visceral adiposity, and insulin resistance.
Conclusions:
- Reduced cardiac autonomic function may serve as an early predictor of decreased diastolic function in metabolic disorders.
- Targeting autonomic dysfunction could be a therapeutic strategy for preventing HFpEF in at-risk populations.
Abstract:
Heart failure due to decreased diastolic function, HFpEF, is a growing health concern with rising prevalence. We examined subclinical cardiac autonomic and diastolic functions in 605 patients with metabolic diseases classified as pre-heart failure. Presence of glucose intolerance or diabetes, or visceral adiposity was significantly associated with reduced cardiac autonomic and diastolic functions. Higher autonomic functions were significantly associated with a parameter of better cardiac diastolic function (E/A) (SDNN: r = 0.306, p < 0.01; HF: r = 0.341, p < 0.01), with the association independent of diabetes, body mass index, visceral adiposity and insulin resistance index. Thus, reduced autonomic function may be a potential predictor for decreased cardiac diastolic functions in metabolic disorders.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...


